In recent days, Boston Scientific announced a forthcoming CFO change, a Cambridge biotech undertook a 1-for-20 reverse stock ...

Jon Monson, currently Boston Scientific's senior vice president for investor relations, will replace Brennan beginning June ...

Subjects in the study were monitored using the LUX-Dx insertable cardiac monitor system to detect arrhythmia recurrence.

This was the stock's third consecutive day of gains.

Shares of Boston Scientific rose sharply Wednesday after the firm posted better-than-expected quarterly results.

Boston Scientific today shared new clinical data supporting multiple therapies at the Heart Rhythm Society (HRS) 2025 Meeting ...

Boston Scientific said that while tariffs pose “unfortunate” headwinds—which are poised to add about $200 million to the cost ...

Boston Scientific stock is up as company officials predict that the ongoing trade war won't hinder double-digit sales growth ...

Shares of the medical device maker soared nearly 10 per cent in premarket trading, as the raised forecast alleviated investor ...

After having served as CFO of Boston Scientific since 2014, Brennan will retire from his executive leadership roles at the ...

Truist analyst Richard Newitter raised the firm’s price target on Boston Scientific (BSX) to $117 from $113 and keeps a Buy rating on the ...

Barclays analyst Matt Miksic raised the firm’s price target on Boston Scientific (BSX) to $125 from $118 and keeps an Overweight rating on the ...